MM relapse from B cell maturation antigen (BCMA) CAR T cell therapy occurs through the cleavage of the extracellular domain of BCMA by γ-secretase (GS), a universally expressed intramembrane protease (26). Here, TNFRSF17 is linked to Miyoshi myopathy.